TY - CONF
T1 - Genome-wide analyses using UK biobank data povide new therapeutic targets for osteoarthritis
AU - Hatzikotoulas, Konstantinos
AU - Tachmazidou, Ioanna
AU - Southam, Lorraine
AU - Esparza-Gordillo, Jorge
AU - Haberland, Valeriia
AU - Zheng, Jie
AU - Johnson, Toby
AU - Koprulu, Mine
AU - Zengini, Eleni
AU - Steinberg, Julia
AU - Wilkinson, Jeremy
AU - Bhatnagar, Sahir
AU - Hoffman, Joshua D
AU - Buchan, Natalie
AU - Suveges, Daniel
AU - Yerges-Armstrong, Laura M
AU - Davey Smith, George
AU - Gaunt, Tom
AU - Scott, Robert
AU - McCarthy, Linda C
AU - Zeggini, Eleftheria
PY - 2019/4
Y1 - 2019/4
N2 - Purpose: Osteoarthritis (OA) is the most prevalent musculoskeletal disease and a leading cause of disability worldwide with huge public health burden. The pathogenesis of OA is complex with multiple environmental and genetic factors implicated in the disease aetiology and progression. The heritability of OA is∼ 50% and previous genetic studies have identified 34 loci in total. Here, we conduct the largest genome-wide association study for OA to date to better understand the genetic architecture of the disease and support the development of disease-modifying therapies.
AB - Purpose: Osteoarthritis (OA) is the most prevalent musculoskeletal disease and a leading cause of disability worldwide with huge public health burden. The pathogenesis of OA is complex with multiple environmental and genetic factors implicated in the disease aetiology and progression. The heritability of OA is∼ 50% and previous genetic studies have identified 34 loci in total. Here, we conduct the largest genome-wide association study for OA to date to better understand the genetic architecture of the disease and support the development of disease-modifying therapies.
U2 - 10.1016/j.joca.2019.02.083
DO - 10.1016/j.joca.2019.02.083
M3 - Conference Abstract
ER -